N. Guiso et al., Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines, VACCINE, 17(19), 1999, pp. 2366-2376
Bicomponent, tricomponent and pertactin DTPa vaccines were tested in sublet
hal aerosol, and lethal and sublethal intranasal murine Bordetella pertussi
s respiratory challenge models. Pertactin and bicomponent vaccines induced
protective immunity against lethality but with little or no bacterial clear
ance. Intranasal challenge discriminated in a reproducible, statistically s
ignificant manner between the efficacies of bicomponent and tricomponent DT
Pa, in agreement with clinical trial data. This discrimination was not obse
rved in the aerosol challenge. Pertactin had a synergistic effect with bico
mponent DTPa. Intranasal challenge may be useful as part of the preclinical
evaluation of new acellular pertussis formulations or DTPa-based combinati
ons. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.